Higia is a company that develops bra inserts that can detect breast cancer risk. Higia was established in 2015 by Jose Antonio Torres and Julian Rios Cantu. Higia aims to help women detect breast cancer risk early through a non-invasive process. The company is based in Mexico City, Mexico.
Higia’s bra inserts product, called EVA, is equipped with biosensors that can identify abnormal temperatures in the breast that can correlate to tumor growth. EVA itself is a thermal sensing bra inserts that women can put into sports bras. EVA would need 60 minutes to collect the needed information to generate a report, which the user can access through the mobile application EVA Health App.
Higia has received a total capital of $5.1 million from 13 investors – 3 among them as lead investors – across four funding rounds since 2017. The company’s most recent financing round was held in October 2018, raising $5 million. Higia has received funding from Sound Ventures, Jessica Livingston, Hummingbird Ventures, Abstract Ventures, and Ashton Kutcher.
Director of Technology
Director of Product Development
Fernando López Martínez
Director of Software
Julián Ríos Cantú
CEO and co-founder
Raymundo González Leal
Director of Artificial Intelligence